Beyer KS, Blasi F, Bacchelli E, Klauck SM, Maestrini E, Poustka A. Mutation analysis of the
coding sequence of the MECP2 gene in infantile autism. Hum Genet 2002; 111:305-9.
Lam CW, Yeung WL, Ko CH, Poon PM, Tong SF, Chan KY, Lo IF, Chan LY, Hui J, Wong
V, et al. Spectrum of mutations in the MECP2 gene in patients with infantile autism and
Rett syndrome. J Med Genet 2000; 37:E41.
Lobo-Menendez F, Sossey-Alaoui K, Bell JM, Copeland-Yates SA, Plank SM, Sanford
SO, Skinner C, Simensen RJ, Schroer RJ, Michaelis RC. Absence of MeCP2 mutations in
patients from the South Carolina autism project. Am J Med Genet 2003; 117B:97-101.
Vourc’h P, Bienvenu T, Beldjord C, Chelly J, Barthelemy C, Muh JP, Andres C. No mutations in the coding region of the Rett syndrome gene MECP2 in 59 autistic patients. Eur J
Hum Genet 2001; 9:556-8.
Shibayama A, Cook Jr EH, Feng J, Glanzmann C, Yan J, Craddock N, Jones IR, Goldman
D, Heston LL, Sommer SS. MECP2 structural and 3’-UTR variants in schizophrenia,
autism and other psychiatric diseases: A possible association with autism. Am J Med Genet
2004; 128B:50-3.
Gauthier J, Joober R, Dube MP, St-Onge J, Bonnel A, Gariepy D, Laurent S, Najafee R,
Lacasse H, St-Charles L, et al. Autism spectrum disorders associated with X chromosome
markers in French-Canadian males. Mol Psychiatry 2006; 11:206-13.
Vincent JB, Melmer G, Bolton PF, Hodgkinson S, Holmes D, Curtis D, Gurling HM.
Genetic linkage analysis of the X chromosome in autism, with emphasis on the fragile X
region. Psychiatr Genet 2005; 15:83-90.
LaSalle JM, Goldstine J, Balmer D, Greco CM. Quantitative localization of heterogeneous
methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 2001; 10:1729-40.
Balmer D, Goldstine J, Rao YM, LaSalle JM. Elevated methyl-CpG-binding protein 2
expression is acquired during postnatal human brain development and is correlated with
alternative polyadenylation. J Mol Med 2003; 81:61-8.
Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. Insight into Rett syndrome:
MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 2002; 11:115-24.
D’Esposito M, Quaderi NA, Ciccodicola A, Bruni P, Esposito T, D’Urso M, Brown SD.
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding
methyl CpG-binding protein, MECP2. Mamm Genome 1996; 7:533-5.
Coy JF, Sedlacek Z, Bachner D, Delius H, Poustka A. A complex pattern of evolutionary
conservation and alternative polyadenylation within the long 3”-untranslated region of the
methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression.
Hum Mol Genet 1999; 8:1253-62.
Reichwald K, Thiesen J, Wiehe T, Weitzel J, Poustka WA, Rosenthal A, Platzer M, Stratling
WH, Kioschis P. Comparative sequence analysis of the MECP2-locus in human and mouse
reveals new transcribed regions. Mamm Genome 2000; 11:182-90.
Kriaucionis S, Bird A. The major form of MeCP2 has a novel N-terminus generated by
alternative splicing. Nucleic Acids Res 2004; 32:1818-23.
Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR,
Scherer SW, Schanen NC, Friez MJ, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet 2004;
36:339-41.
Adachi M, Keefer EW, Jones FS. A Segment of the Mecp2 promoter is sufficient to drive
expression in neurons. Hum Mol Genet 2005; 14:3709-22.
Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM. Multiple pathways regulate
MeCP2 expression in normal brain development and exhibit defects in autism-spectrum
disorders. Hum Mol Genet 2004; 13:629-39.
Pelphrey K, Adolphs R, Morris JP. Neuroanatomical substrates of social cognition dysfunction in autism. Ment Retard Dev Disabil Res Rev 2004; 10:259-71.
Evans JC, Archer HL, Whatley SD, Kerr A, Clarke A, Butler R. Variation in exon 1 coding
region and promoter of MECP2 in Rett syndrome and controls. Eur J Hum Genet 2005;
13:124-6.
Braunschweig D, Simcox T, Samaco RC, LaSalle JM. X-Chromosome inactivation ratios
affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2‐/+ mouse
brain. Hum Mol Genet 2004; 13(12):1275-86.
Liu J, Francke U. Identification of cis-regulatory elements for MECP2 expression. Hum
Mol Genet 2006; 15(11):1769-82.
Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Hum Mol Genet 2005; 14:483-92.
Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC, Jaenisch R, Greenberg
ME. Derepression of BDNF transcription involves calcium-dependent phosphorylation of
MeCP2. Science 2003; 302:885-9.
Chang Q, Khare G, Dani V, Nelson S, Jaenisch R. The disease progression of Mecp2 mutant
mice is affected by the level of BDNF expression. Neuron 2006; 49:341-8.
Horike S, Cai S, Miyano M, Cheng J, Kohwi-Shigematsu T. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005; 37:31-40.
Jiang YH, Sahoo T, Michaelis RC, Bercovich D, Bressler J, Kashork CD, Liu Q, Shaffer
LG, Schroer RJ, Stockton DW, et al. A mixed epigenetic/genetic model for oligogenic
inheritance of autism with a limited role for UBE3A. Am J Med Genet 2004; 131A:1-10.
Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on
epigenetic gene regulation. Mol Cell Biol 2003; 23:5293-300.
